Abstract
Pulmonary toxicity is a prominent side effect of many anticancer drugs. Although the marrow-sparing antibiotic bleomycin has been identified as the antineoplastic agent with the most serious, life threatening and dose limiting pulmonary toxicity, a number of other drugs have also been reported to produce lung injury; these include carmustine, chlorambucil, cyclophosphamide, cytarabine HCl, estramustine, lomustine, melphalan, methotrexate, mitomycin, procarbazine and semustine1. Ionizing radiation, a common adjunct to cancer chemotherapy, is also a powerful pulmonary toxin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
The Medical Letter 29:29–36 (1987).
Adamson, IYR and Bowden, DH. (1974) Amer. J. Pathol. 77:185–198.
Aso, Y., Yoneda, K. and Kikkawa, Y. (1976) Lab Invest. 35:558.
Adamson, IYR and Bowden, DH. (1979) Amer. J. Pathol. 96:531–538.
Nicolson, GL and Custead, SE. (1985) Cane. Res. 45:331–336.
Tom, WM and Montgomery, MR. (1980) Toxicol. Appl. Pharmacol. 53:64–74.
Newman, RA, Kimberly, PJ, Stweart, JA and Kelley, J. (1980) Cane. Res. 40:3621–3626.
Catravas, JD, Watkins, CA and Newman, RA. (1987) Amer. Rev. Resp. Dis. 135:A257.
Lazo, JS, Catravas, JD and Gillis, CN. (1981) Biochem. Pharmacol. 30:2577–2584.
Lazo, JS, Catravas, JD, Dobuler, KJ and Gillis, CN. (1983) Toxicol. Appl. Pharmacol. 69:276–282.
Catravas, JD, Lazo, JS, Dobuler, KD, Mills, LR and Gillis, CN. (1983) Amer. Rev. Resp. Dis. 128:740–746.
Lazo, JS. (1981) Toxicol. Appl. Pharmacol. 59:395–404.
Sorensen, PG, Romer, FK and Cortes, S. (1984) Eur. J. Cane. Clin. Oncol. 20:1405–1408.
Newman, RA, Hacker, MP, Kimberly, PJ and Braddock, JM. (1981) Toxicol. Appl. Pharmacol. 61:469–474.
Catravas, JD, Lazo, JS and Gillis, CN. (1981) J. Pharmacol Exp. Ther. 217:524–529.
Chandler, DB and Giri, SN. (1983) Amer. Rev. Resp. Dis. 128:71–76.
Catravas, JD. (1986) Adv. Exp. Med. 198:445–451.
Catravas, JD and Burch, SE. (1987) Toxicol Appl. Pharmacol.
Lazo, JS, Lynch, TJ and McCallister, J. (1983) Amer. Rev. Resp. Dis. 134:73–78.
Lazo, JS. (1986) Biochem. Pharmacol. 35:1919–1923.
Adamson, IYR and Bowden, DA. (1983) Amer. J. Pathol. 112:274.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Catravas, J.D. (1988). Pulmonary Toxicity of Anticancer Drugs: Alterations in Endothelial Cell Function. In: Hacker, M.P., Lazo, J.S., Tritton, T.R. (eds) Organ Directed Toxicities of Anticancer Drugs. Developments in Oncology, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2023-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2023-4_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9205-0
Online ISBN: 978-1-4613-2023-4
eBook Packages: Springer Book Archive